ARID1A and cholangiocarcinoma: In CCA tumors, decreased expression of ARID1A was associated with CCA progression and metastasis, indicating the tumor-suppressor function of ARID1A in CCA (Chan-on et al., 2013; Namjan et al., 2020; Zhao et al., 2021).